Since our inception in 1978, Breast Cancer Trials has contributed to more than 1,277 publications and many of these research results have changed practice in the treatment and prevention of breast cancer.

The publication of the results of clinical trials research in scientific journals or a periodic publication fulfills the researchers ethical obligations to research participants and the general community, and it also contributes to medical knowledge for the benefit and treatment of patients.

A number of new publications in the reporting period, which answered important scientific questions, are expected to translate into improved outcomes for women.

The results highlight our unique collaboration at Breast Cancer Trials (BCT) between researchers, clinical trial participants and our generous supporters. This collaboration means new and better treatments can be found sooner and improve outcomes for people diagnosed or at risk of breast cancer.

BCT contributed to 46 publications in 2022/23, which consisted of:

  • 10 journal/epub publications in peer reviewed journals.
  • 3 presentations at an annual conference.
  • 32 abstracts/posters.
  • 1 editorial.

 

NEXT – ASSESSING THE EFFECT OF BREAST CANCER TREATMENT ON OVARIAN FUNCTION